Akzo Nobel NV

Pharmaceuticals
Netherlands
Executive 1Mr. Ton Buchner, Chairman of the Management Board; Chief Executive | Chairman of the Management Board; Chief Executive
Executive 2Mr. Marten Booisma, Management Board Member; | Senior Executive Vice President;
Earnings Per Share Growth (%)-25.50%
Cost of Goods Sold (US$ Millions)$10,546
Current Liabilities (US$ Millions)$6,017
Total Assets (US$ Millions)$7,505
Long Term Debt (Millions)$3,072
Return on Equity11.05%
Revenue (US$ Millions)$17,274
Total Company Assets$19,812
Revenue Growth (%)-3.91%
Net Income (US$ Millions)$751
Earnings Per Share (US$)$2.70
Total Equity (US$ Millions)$7,038
Profit Margin (%)4.35%
Debt To Equity Ratio (%)0.44%
Inventories (Millions)$1,878